{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:08:56Z","timestamp":1792804136227,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072979"],"award-info":[{"award-number":["P30AG072979"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40290-025-00562-1","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:12:24Z","timestamp":1743736344000},"page":"59-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Importance of Including Underserved Populations in Research"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-7718","authenticated-orcid":false,"given":"Kayla R.","family":"Mehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Morain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-5077","authenticated-orcid":false,"given":"Emily A.","family":"Largent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"562_CR1","unstructured":"Health Resources & Services Administration (HRSA). Serving vulnerable and underserved populations. 2022. Available from: https:\/\/www.hhs.gov\/guidance\/sites\/default\/files\/hhs-guidance-documents\/006_Serving_Vulnerable_and_Underserved_Populations_0.pdf. [Accessed 30 Aug 2024]."},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1377\/hlthaff.2016.0158","volume":"35","author":"TS Purnell","year":"2016","unstructured":"Purnell TS, Calhoun EA, Golden SH, et al. Achieving health equity: closing the gaps in health care disparities, interventions, and research. Health Aff. 2016;35:1410\u20135.","journal-title":"Health Aff"},{"key":"562_CR3","first-page":"1","volume":"7","author":"MA Ezzat","year":"2023","unstructured":"Ezzat MA. Identifying barriers to healthcare access among underserved populations: a descriptive study. J Adv Anal Healthcare Manage. 2023;7:1\u201317.","journal-title":"J Adv Anal Healthcare Manage."},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.31486\/toj.19.0079","volume":"20","author":"BG Gordon","year":"2020","unstructured":"Gordon BG. Vulnerability in research: basic ethical concepts and general approach to review. Ochsner J. 2020;20:34\u20138.","journal-title":"Ochsner J"},{"key":"562_CR5","unstructured":"US Department of Health and Human Services. Code of Federal Regulations. 2019. Available from: https:\/\/www.ecfr.gov\/current\/title-45\/subtitle-A\/subchapter-A\/part-46. [Accessed 3 Nov 2019]."},{"key":"562_CR6","unstructured":"National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. 1979. Available from: https:\/\/www.hhs.gov\/ohrp\/sites\/default\/files\/the-belmont-report-508c_FINAL.pdf. [Accessed 21 Mar 2025]."},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1467-8519.2008.00631.x","volume":"22","author":"SA Hurst","year":"2008","unstructured":"Hurst SA. Vulnerability in research and health care; describing the elephant in the room? Bioethics. 2008;22:191\u2013202.","journal-title":"Bioethics"},{"key":"562_CR8","unstructured":"Nakintu S. Diversity, equity and inclusion: key terms and definitions. National Association of Counties (NACo). 2021. Available from: https:\/\/www.naco.org\/resources\/featured\/key-terms-definitions-diversity-equity-inclusion. [Accessed 3 Nov 2021]."},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2105\/AJPH.2012.301200","volume":"103","author":"W Rogers","year":"2013","unstructured":"Rogers W, Lange MM. Rethinking the vulnerability of minority populations in research. Am J Public Health. 2013;103:2141\u20136.","journal-title":"Am J Public Health"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1353\/hpu.0.0323","volume":"21","author":"DP Scharff","year":"2010","unstructured":"Scharff DP, Mathews KJ, Jackson P, et al. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010;21:879\u201397.","journal-title":"J Health Care Poor Underserved"},{"key":"562_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001918","volume":"12","author":"SS Oh","year":"2015","unstructured":"Oh SS, Galanter J, Thakur N, et al. Diversity in clinical and biomedical research: a promise yet to be fulfilled. PLoS Med. 2015;12:e1001918.","journal-title":"PLoS Med"},{"key":"562_CR12","unstructured":"US Department of Health and Human Services, Office of Inspector General. Plans and enrollment often fell short for underrepresented groups in a sample of NIH-funded clinical trials. 2024. Available from: https:\/\/oig.hhs.gov\/reports\/all\/2024\/plans-and-enrollment-often-fell-short-for-underrepresented-groups-in-a-sample-of-nih-funded-clinical-trials\/. [Accessed 7 Oct 2024]."},{"key":"562_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/15562646221138450","volume":"18","author":"L Gelinas","year":"2023","unstructured":"Gelinas L, Strauss DH, Chen Y, et al. Protecting the vulnerable and including the under-represented: IRB practices and attitudes. J Empiric Res Hum Res Ethics. 2023;18:58\u201368.","journal-title":"J Empiric Res Hum Res Ethics."},{"key":"562_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.611","volume":"7","author":"ME Heffernan","year":"2023","unstructured":"Heffernan ME, Barrera L, Guzman ZR, et al. Barriers and facilitators to recruitment of underrepresented research participants: perspectives of clinical research coordinators. J Clin Transl Sci. 2023;7:e193.","journal-title":"J Clin Transl Sci."},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/15265161.2022.2063434","volume":"23","author":"P Friesen","year":"2023","unstructured":"Friesen P, Gelinas L, Kirby A, et al. IRBs and the protection-inclusion dilemma: finding a balance. Am J Bioeth. 2023;23:75\u201388.","journal-title":"Am J Bioeth"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10900-013-9798-2","volume":"39","author":"S-H Kim","year":"2014","unstructured":"Kim S-H, Tanner A, Friedman DB, et al. Barriers to clinical trial participation: a comparison of rural and urban communities in South Carolina. J Community Health. 2014;39:562\u201371.","journal-title":"J Community Health"},{"key":"562_CR17","unstructured":"National Academies of Sciences, Engineering, and Medicine, Policy and Global Affairs, Committee on Women in Science, Engineering, and Medicine, et al. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. Washington, DC: National Academies Press; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK584407\/. [Accessed 21 Mar 2025]."},{"key":"562_CR18","unstructured":"Crenshaw K. Demarginalizing the intersection of race and sex: a black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. The University of Chicago Legal Forum; 1989. Available from: http:\/\/chicagounbound.uchicago.edu\/uclf\/vol1989\/iss1\/8 (1989). [Accessed 21 Mar 2025]."},{"key":"562_CR19","volume-title":"Justice and the politics of difference","author":"IM Young","year":"2011","unstructured":"Young IM. Justice and the politics of difference. Princeton: Princeton University Press; 2011."},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1748-720X.2000.tb00685.x","volume":"28","author":"NM King","year":"2000","unstructured":"King NM. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics. 2000;28:332\u201343.","journal-title":"J Law Med Ethics"},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;11:156\u201364.","journal-title":"Contemp Clin Trials Commun."},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.2105\/AJPH.2011.300279","volume":"101","author":"JA Fisher","year":"2011","unstructured":"Fisher JA, Kalbaugh CA. Challenging assumptions about minority participation in US clinical research. Am J Public Health. 2011;101:2217\u201322.","journal-title":"Am J Public Health"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1056\/NEJMp0801872","volume":"358","author":"C Elliott","year":"2008","unstructured":"Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358:2316\u20137.","journal-title":"N Engl J Med"},{"key":"562_CR24","first-page":"34","volume":"28","author":"GJ McDougall","year":"2002","unstructured":"McDougall GJ, Rew L, Walker LO, et al. Serving the underserved through research. Reflect Nurs Leadersh. 2002;28:34\u20137.","journal-title":"Reflect Nurs Leadersh"},{"key":"562_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/15265161.2019.1701731","volume":"20","author":"D MacKay","year":"2020","unstructured":"MacKay D, Saylor KW. Four faces of fair subject selection. Am J Bioeth. 2020;20:5\u201319.","journal-title":"Am J Bioeth"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1056\/NEJMp2215609","volume":"388","author":"AL Schwartz","year":"2023","unstructured":"Schwartz AL, Alsan M, Morris AA, et al. Why diverse clinical trial participation matters. N Engl J Med. 2023;388:1252\u20134.","journal-title":"N Engl J Med"},{"key":"562_CR27","unstructured":"US Food and Drug Administration (FDA). Enhancing the diversity of clinical trial populations: eligibility criteria, enrollment practices, and trial designs guidance for industry. 2024. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial. [Accessed 9 Oct 2024]."},{"key":"562_CR28","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","volume":"283","author":"EJ Emanuel","year":"2000","unstructured":"Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701\u201311.","journal-title":"JAMA"},{"key":"562_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/lrh2.10413","volume":"8","author":"SR Morain","year":"2024","unstructured":"Morain SR, O\u2019Rourke PP, Ali J, et al. Post-trial responsibilities in pragmatic clinical trials: fulfilling the promise of research to drive real-world change. Learn Health Syst. 2024;8:e10413.","journal-title":"Learn Health Syst."},{"key":"562_CR30","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","volume":"104","author":"S George","year":"2014","unstructured":"George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104:e16-31.","journal-title":"Am J Public Health"},{"key":"562_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41582-022-00688-9","volume":"18","author":"L Rochester","year":"2022","unstructured":"Rochester L, Carroll C. Implications of research that excludes under-served populations. Nat Rev Neurol. 2022;18:449\u201350.","journal-title":"Nat Rev Neurol"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12913-022-07829-2","volume":"22","author":"NC Coombs","year":"2022","unstructured":"Coombs NC, Campbell DG, Caringi J. A qualitative study of rural healthcare providers\u2019 views of social, cultural, and programmatic barriers to healthcare access. BMC Health Serv Res. 2022;22:438.","journal-title":"BMC Health Serv Res"},{"key":"562_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4278\/ajhp.130514-QUAL-247","volume":"29","author":"DB Friedman","year":"2015","unstructured":"Friedman DB, Foster C, Bergeron CD, et al. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. Am J Health Promot. 2015;29:332\u20138.","journal-title":"Am J Health Promot"},{"key":"562_CR34","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2021.876","volume":"6","author":"SR Passmore","year":"2022","unstructured":"Passmore SR, Kisicki A, Gilmore-Bykovskyi A, et al. \u2018There\u2019s not much we can do \u2026\u2019 researcher-level barriers to the inclusion of underrepresented participants in translational research. J Clin Transl Sci. 2022;6:e4.","journal-title":"J Clin Transl Sci."},{"key":"562_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/10810730.2014.908985","volume":"20","author":"A Tanner","year":"2015","unstructured":"Tanner A, Kim S-H, Friedman DB, et al. Barriers to medical research participation as perceived by clinical trial investigators: communicating with rural and African American communities. J Health Commun. 2015;20:88\u201396.","journal-title":"J Health Commun"},{"key":"562_CR36","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cts.13220","volume":"15","author":"SE Watson","year":"2022","unstructured":"Watson SE, Smith P, Snowden J, et al. Facilitators and barriers to pediatric clinical trial recruitment and retention in rural and community settings: a scoping review of the literature. Clin Transl Sci. 2022;15:838\u201353.","journal-title":"Clin Transl Sci"},{"key":"562_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/jrh.12684","volume":"39","author":"JJ Lister","year":"2023","unstructured":"Lister JJ, Joudrey PJ. Rural mistrust of public health interventions in the United States: a call for taking the long view to improve adoption. J Rural Health. 2023;39:18\u201320.","journal-title":"J Rural Health"},{"key":"562_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthplace.2020.102396","volume":"64","author":"M Statz","year":"2020","unstructured":"Statz M, Evers K. Spatial barriers as moral failings: what rural distance can teach us about women\u2019s health and medical mistrust. Health Place. 2020;64:102396.","journal-title":"Health Place"},{"key":"562_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103344","volume":"97","author":"NH Kim","year":"2021","unstructured":"Kim NH, Wilson N, Mashburn T, et al. Lessons learned recruiting a diverse sample of rural study participants during the COVID-19 pandemic. Int J Drug Policy. 2021;97:103344.","journal-title":"Int J Drug Policy"},{"key":"562_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s10900-013-9659-z","volume":"38","author":"DB Friedman","year":"2013","unstructured":"Friedman DB, Bergeron CD, Foster C, et al. What do people really know and think about clinical trials? A comparison of rural and urban communities in the south. J Community Health. 2013;38:642\u201351.","journal-title":"J Community Health"},{"key":"562_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.conctc.2016.12.004","volume":"5","author":"M Geana","year":"2017","unstructured":"Geana M, Erba J, Krebill H, et al. Searching for cures: inner-city and rural patients\u2019 awareness and perceptions of cancer clinical trials. Contemp Clin Trials Commun. 2017;5:72\u20139.","journal-title":"Contemp Clin Trials Commun."},{"key":"562_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/17407745221090733","volume":"19","author":"NJ McPhee","year":"2022","unstructured":"McPhee NJ, Nightingale CE, Harris SJ, et al. Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: a scoping review. Clin Trials. 2022;19:464\u201376.","journal-title":"Clin Trials"},{"key":"562_CR43","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.3390\/ijerph16234643","volume":"16","author":"H Greville","year":"2019","unstructured":"Greville H, Haynes E, Kagie R, et al. \u2018It shouldn\u2019t be this hard\u2019: exploring the challenges of rural health research. Int J Environ Res Public Health. 2019;16:4643.","journal-title":"Int J Environ Res Public Health"},{"key":"562_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkac017","volume":"6","author":"LK Ko","year":"2022","unstructured":"Ko LK, Scarinci IC, Bouchard EG, et al. A framework for equitable partnerships to promote cancer prevention and control in rural settings. JNCI Cancer Spectr. 2022;6:pkac017.","journal-title":"JNCI Cancer Spectr"},{"key":"562_CR45","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.15585\/mmwr.mm6744a2","volume":"67","author":"TW Wang","year":"2018","unstructured":"Wang TW, Asman K, Gentzke AS, et al. Tobacco product use among adults: United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1225\u201332.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"562_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.13031\/2013.9054","volume":"8","author":"RH Rautiainen","year":"2002","unstructured":"Rautiainen RH, Reynolds SJ. Mortality and morbidity in agriculture in the United States. J Agric Saf Health. 2002;8:259\u201376.","journal-title":"J Agric Saf Health"},{"key":"562_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jech.57.1.29","volume":"57","author":"SE Parks","year":"2003","unstructured":"Parks SE, Housemann RA, Brownson RC. Differential correlates of physical activity in urban and rural adults of various socioeconomic backgrounds in the United States. J Epidemiol Community Health. 2003;57:29\u201335.","journal-title":"J Epidemiol Community Health"},{"key":"562_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","volume":"44","author":"LT Clark","year":"2019","unstructured":"Clark LT, Watkins L, Pi\u00f1a IL, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44:148\u201372.","journal-title":"Curr Probl Cardiol"},{"key":"562_CR49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01132","author":"KM Winkfield","year":"2018","unstructured":"Winkfield KM, Phillips JK, Joffe S, et al. Addressing financial barriers to patient participation in clinical trials: ASCO policy statement. J Clin Oncol. 2018. https:\/\/doi.org\/10.1200\/JCO.18.01132. (Epub ahead of print).","journal-title":"J Clin Oncol"},{"key":"562_CR50","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1634\/theoncologist.2019-0146","volume":"24","author":"RD Nipp","year":"2019","unstructured":"Nipp RD, Lee H, Gorton E, et al. Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention. Oncologist. 2019;24:1048\u201355.","journal-title":"Oncologist"},{"key":"562_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.23157","volume":"112","author":"JG Ford","year":"2008","unstructured":"Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112:228\u201342.","journal-title":"Cancer"},{"key":"562_CR52","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/jgs.16875","volume":"68","author":"ND Forsat","year":"2020","unstructured":"Forsat ND, Palmowski A, Palmowski Y, et al. Recruitment and retention of older people in clinical research: a systematic literature review. J Am Geriatr Soc. 2020;68:2955\u201363.","journal-title":"J Am Geriatr Soc"},{"key":"562_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10730-015-9270-z","volume":"27","author":"AF Cook","year":"2015","unstructured":"Cook AF, Hoas H. Exploring the potential for moral hazard when clinical trial research is conducted in rural communities: do traditional ethics concepts apply? HEC Forum. 2015;27:171\u201387.","journal-title":"HEC Forum"},{"key":"562_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0033-3549(04)50262-5","volume":"118","author":"LE Boulware","year":"2003","unstructured":"Boulware LE, Cooper LA, Ratner LE, et al. Race and trust in the health care system. Public Health Rep. 2003;118:358\u201365.","journal-title":"Public Health Rep"},{"key":"562_CR55","first-page":"951","volume":"97","author":"DT Brandon","year":"2005","unstructured":"Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97:951\u20136.","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"562_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/08964289.2019.1619511","volume":"45","author":"J Jaiswal","year":"2019","unstructured":"Jaiswal J, Halkitis PN. Towards a more inclusive and dynamic understanding of medical mistrust informed by science. Behav Med. 2019;45(2):79\u201385.","journal-title":"Behav Med"},{"key":"562_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030019","volume":"3","author":"D Wendler","year":"2006","unstructured":"Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3:e19.","journal-title":"PLoS Med"},{"key":"562_CR58","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cncr.32755","volume":"126","author":"SJ Niranjan","year":"2020","unstructured":"Niranjan SJ, Martin MY, Fouad MN, et al. Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials. Cancer. 2020;126:1958\u201368.","journal-title":"Cancer"},{"key":"562_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.envsci.2021.04.014","volume":"122","author":"AS Fernandez-Bou","year":"2021","unstructured":"Fernandez-Bou AS, Ortiz-Partida JP, Dobbin KB, et al. Underrepresented, understudied, underserved: gaps and opportunities for advancing justice in disadvantaged communities. Environ Sci Policy. 2021;122:92\u2013100.","journal-title":"Environ Sci Policy"},{"key":"562_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/107327481602300404","volume":"23","author":"LM Hamel","year":"2016","unstructured":"Hamel LM, Penner LA, Albrecht TL, et al. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016;23:327\u201337.","journal-title":"Cancer Control"},{"key":"562_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.soc.2022.08.005","volume":"32","author":"G Keegan","year":"2023","unstructured":"Keegan G, Crown A, Joseph K-A. Diversity, equity, and inclusion in clinical trials. Surg Oncol Clin N Am. 2023;32:221\u201332.","journal-title":"Surg Oncol Clin N Am"},{"key":"562_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303112","volume":"19","author":"LE Wolf","year":"2024","unstructured":"Wolf LE, Kench S, Ledford CJW. A taxing problem: the impacts of research payment practices on participants and inclusive research. PLoS\u00a0One. 2024;19: e0303112.","journal-title":"PLoS\u00a0One"},{"key":"562_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMp2115621","volume":"386","author":"K Armstrong","year":"2022","unstructured":"Armstrong K, Ritchie C. Research participation in marginalized communities: overcoming barriers. N Engl J Med. 2022;386:203\u20135.","journal-title":"N Engl J Med"},{"key":"562_CR64","unstructured":"Passel JS, Krogstad JM. What we know about unauthorized immigrants living in the U.S. Pew Research Center. 2024. Available from: https:\/\/www.pewresearch.org\/short-reads\/2024\/07\/22\/what-we-know-about-unauthorized-immigrants-living-in-the-us\/. [Accessed 3 Nov 2024]."},{"key":"562_CR65","doi-asserted-by":"publisher","first-page":"9716","DOI":"10.1038\/s41598-022-13733-w","volume":"12","author":"M Alshakhs","year":"2022","unstructured":"Alshakhs M, Jackson B, Ikponmwosa D, et al. Multimorbidity patterns across race\/ethnicity as stratified by age and obesity. Sci Rep. 2022;12:9716.","journal-title":"Sci Rep"},{"key":"562_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.amepre.2015.07.036","volume":"50","author":"SF Wallington","year":"2016","unstructured":"Wallington SF, Dash C, Sheppard VB, et al. Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med. 2016;50:111\u20137.","journal-title":"Am J Prev Med"},{"key":"562_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/gbae028","volume":"79","author":"S Jain","year":"2024","unstructured":"Jain S, Bey GS, Forrester SN, et al. Aging, race, and health disparities: recommendations from the Research Centers Collaborative Network. J Gerontol B Psychol Sci Soc Sci. 2024;79: gbae028.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"562_CR68","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1001\/jamaophthalmol.2023.4638","volume":"141","author":"A Bains","year":"2023","unstructured":"Bains A, Osathanugrah P, Sanjiv N, et al. Diverse research teams and underrepresented groups in clinical studies. JAMA Ophthalmol. 2023;141:1037\u201344.","journal-title":"JAMA Ophthalmol."},{"key":"562_CR69","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamaoncol.2018.0492","volume":"4","author":"EA Largent","year":"2018","unstructured":"Largent EA, Lynch HF. Addressing financial barriers to enrollment in clinical trials. JAMA Oncol. 2018;4:913\u20134.","journal-title":"JAMA Oncol"},{"key":"562_CR70","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1200\/JCO.23.01149","volume":"42","author":"WL Schpero","year":"2024","unstructured":"Schpero WL, Takvorian SU, Blickstein D, et al. Association between state Medicaid policies and accrual of Black or Hispanic patients to cancer clinical trials. J Clin Oncol. 2024;42:3238\u201346.","journal-title":"J Clin Oncol"},{"key":"562_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pop.2016.09.002","volume":"44","author":"V Morelli","year":"2017","unstructured":"Morelli V. An introduction to primary care in underserved populations: definitions, scope, and challenges. Prim Care. 2017;44:1\u20139.","journal-title":"Prim Care"},{"key":"562_CR72","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s13187-021-01994-4","volume":"37","author":"ND Hernandez","year":"2021","unstructured":"Hernandez ND, Durant R, Lisovicz N, et al. African American cancer survivors\u2019 perspectives on cancer clinical trial participation in a safety-net hospital: considering the role of the social determinants of health. J Cancer Educ. 2021;37:1589.","journal-title":"J Cancer Educ"},{"key":"562_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1073110518766006","volume":"46","author":"S Gehlert","year":"2018","unstructured":"Gehlert S, Mozersky J. Seeing beyond the margins: challenges to informed inclusion of vulnerable populations in research. J Law Med Ethics. 2018;46:30\u201343.","journal-title":"J Law Med Ethics"},{"key":"562_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1017\/cts.2020.12","volume":"4","author":"R Croff","year":"2020","unstructured":"Croff R, Gowen LK, Lindauer A, et al. Including older rural adults in research: practical guidance for addressing the NIH inclusion across the lifespan policy. J Clin Transl Sci. 2020;4:431\u20136.","journal-title":"J Clin Transl Sci."},{"key":"562_CR75","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12889-024-18036-5","volume":"24","author":"A Bertolazzi","year":"2024","unstructured":"Bertolazzi A, Quaglia V, Bongelli R. Barriers and facilitators to health technology adoption by older adults with chronic diseases: an integrative systematic review. BMC Public Health. 2024;24:506.","journal-title":"BMC Public Health"},{"key":"562_CR76","doi-asserted-by":"publisher","DOI":"10.2196\/46522","volume":"7","author":"A Money","year":"2024","unstructured":"Money A, Hall A, Harris D, et al. Barriers to and facilitators of older people\u2019s engagement with web-based services: qualitative study of adults aged >75 years. JMIR Aging. 2024;7:e46522.","journal-title":"JMIR Aging."},{"key":"562_CR77","doi-asserted-by":"publisher","first-page":"004695802210962","DOI":"10.1177\/00469580221096272","volume":"59","author":"F Mubarak","year":"2022","unstructured":"Mubarak F, Suomi R. Elderly forgotten? Digital exclusion in the information age and the rising grey digital divide. Inquiry. 2022;59:00469580221096272.","journal-title":"Inquiry"},{"key":"562_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semradonc.2021.11.003","volume":"32","author":"IM Bumanlag","year":"2022","unstructured":"Bumanlag IM, Jaoude JA, Rooney MK, et al. Exclusion of older adults from cancer clinical trials: review of the literature and future recommendations. Semin Radiat Oncol. 2022;32:125\u201334.","journal-title":"Semin Radiat Oncol."},{"key":"562_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2024.104663","volume":"156","author":"B Idnay","year":"2024","unstructured":"Idnay B, Fang Y, Stanley E, et al. Promoting equity in clinical research: the role of social determinants of health. J Biomed Inform. 2024;156: 104663.","journal-title":"J Biomed Inform"},{"key":"562_CR80","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/JAD-201081","volume":"80","author":"KK Indorewalla","year":"2021","unstructured":"Indorewalla KK, O\u2019Connor MK, Budson AE, et al. Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in Alzheimer\u2019s disease research. J Alzheimers Dis. 2021;80:927\u201340.","journal-title":"J Alzheimers Dis"},{"key":"562_CR81","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1200\/JCO.19.00250","volume":"38","author":"EA Largent","year":"2020","unstructured":"Largent EA, Heffernan KG, Joffe S, et al. Paying clinical trial participants: legal risks and mitigation strategies. J Clin Oncol. 2020;38:532\u20137.","journal-title":"J Clin Oncol"},{"key":"562_CR82","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/ageing\/afab147","volume":"50","author":"T Buttgereit","year":"2021","unstructured":"Buttgereit T, Palmowski A, Forsat N, et al. Barriers and potential solutions in the recruitment and retention of older patients in clinical trials: lessons learned from six large multicentre randomized controlled trials. Age Ageing. 2021;50:1988\u201396.","journal-title":"Age Ageing"},{"key":"562_CR83","unstructured":"Bureau UC. Measuring racial and ethnic diversity for the 2020 Census. 2021. Available from: https:\/\/www.census.gov\/newsroom\/blogs\/random-samplings\/2021\/08\/measuring-racial-ethnic-diversity-2020-census.html. [Accessed 9 Oct 2024]."},{"key":"562_CR84","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22515","volume":"6","author":"H Pittell","year":"2023","unstructured":"Pittell H, Calip GS, Pierre A, et al. Racial and ethnic inequities in US oncology clinical trial participation from 2017 to 2022. JAMA Netw Open. 2023;6:e2322515.","journal-title":"JAMA Netw Open"},{"key":"562_CR85","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23751","volume":"4","author":"C Schwartz","year":"2021","unstructured":"Schwartz C, Chukwudozie IB, Tejeda S, et al. Association of population screening for breast cancer risk with use of mammography among women in medically underserved racial and ethnic minority groups. JAMA Netw Open. 2021;4:e2123751.","journal-title":"JAMA Netw Open"},{"key":"562_CR86","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are the symptoms of Down syndrome? National Institutes of Health (NIH). 2024. Available from: https:\/\/www.nichd.nih.gov\/health\/topics\/down\/conditioninfo\/symptoms. [Accessed 9 Oct 2024]."},{"key":"562_CR87","unstructured":"US Census Bureau. 2020 Census illuminates racial and ethnic composition of the country. 2021. Available from: https:\/\/www.census.gov\/library\/stories\/2021\/08\/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html. [Accessed 9 Oct 2024]."},{"key":"562_CR88","unstructured":"National Institutes of Health (NIH). Working group on disabilities: subgroup report. 1 December 2022. Available from: https:\/\/www.acd.od.nih.gov\/documents\/presentations\/12092022_WGD_Disabilities_Subgroup_Report.pdf. [Accessed 9 Oct 2024]."},{"key":"562_CR89","unstructured":"U.S. Government Accountability Office. Why health care is harder to access in rural America. 2024. Available from: https:\/\/www.gao.gov\/blog\/why-health-care-harder-access-rural-america. [Accessed 9 Oct 2024]."},{"key":"562_CR90","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/d41586-023-02464-1","volume":"620","author":"S Reardon","year":"2023","unstructured":"Reardon S. Alzheimer\u2019s drug trials plagued by lack of racial diversity. Nature. 2023;620:256\u20137.","journal-title":"Nature"},{"key":"562_CR91","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.trci.2018.10.006","volume":"4","author":"A Strydom","year":"2018","unstructured":"Strydom A, Coppus A, Blesa R, et al. Alzheimer\u2019s disease in Down syndrome: an overlooked population for prevention trials. Alzheimers Dement (N Y). 2018;4:703\u201313.","journal-title":"Alzheimers Dement (N Y)."},{"key":"562_CR92","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/07317115.2022.2043977","volume":"46","author":"BS Olivari","year":"2023","unstructured":"Olivari BS, Jeffers EM, Tang KW, et al. Improving brain health for populations disproportionately affected by Alzheimer\u2019s disease and related dementias. Clin Gerontol. 2023;46:128\u201332.","journal-title":"Clin Gerontol"},{"key":"562_CR93","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25805","volume":"5","author":"WY Xu","year":"2022","unstructured":"Xu WY, Jung J, Retchin SM, et al. Rural-urban disparities in diagnosis of early-onset dementia. JAMA Netw Open. 2022;5: e2225805.","journal-title":"JAMA Netw Open"},{"key":"562_CR94","unstructured":"National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Committee on Women in Science, Engineering, and Medicine; Committee on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research; Bibbins-Domingo K, Helman A, editors. Washington (DC): National Academies Press (US); 2022."},{"key":"562_CR95","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1200\/JOP.2010.000158","volume":"7","author":"S Virani","year":"2011","unstructured":"Virani S, Burke L, Remick SC, et al. Barriers to recruitment of rural patients in cancer clinical trials. J Oncol Pract. 2011;7:172\u20137.","journal-title":"J Oncol Pract"},{"key":"562_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12961-016-0164-6","volume":"15","author":"D Bracken-Roche","year":"2017","unstructured":"Bracken-Roche D, Bell E, Macdonald ME, et al. The concept of \u2018vulnerability\u2019 in research ethics: an in-depth analysis of policies and guidelines. Health Res Policy Syst. 2017;15:8.","journal-title":"Health Res Policy Syst."}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-025-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-025-00562-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-025-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:02:23Z","timestamp":1744160543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-025-00562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s40290-025-00562-1","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"16 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Kayla R. Mehl, Stephanie R. Morain, and Emily A. Largent have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest\/Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"KRM: led the writing of the original draft, conducted the revision and editing processes, and prepared the final draft. SRM and EL: provided critical feedback and helped shape the revision and editing of the manuscript. EL: additionally conceptualized the initial framework and outline of the study. All authors have read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}